These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Drug-induced prolongation of the QT interval. Curigliano G; Cipolla C; de Braud F N Engl J Med; 2004 Jun; 350(25):2618-21; author reply 2618-21. PubMed ID: 15208787 [No Abstract] [Full Text] [Related]
12. QT interval prolongation and ventricular fibrillation in childhood end-stage renal disease. Kim GB; Cho HY; Kwon BS; Bae EJ; Noh CI; Choi JY; Yun YS; Choi Y; Ha JW Int J Cardiol; 2008 Jul; 127(3):e126-8. PubMed ID: 17714808 [TBL] [Abstract][Full Text] [Related]
13. [Adverse drug reactions. QT-prolongation and torsade-de-pointes arrhythmias]. Haffner S; Lapp H; Thürmann PA Dtsch Med Wochenschr; 2002 May; 127(19):1022-4. PubMed ID: 11997870 [No Abstract] [Full Text] [Related]
14. Diphenhydramine induced QT prolongation and torsade de pointes: An uncommon effect of a common drug. Husain Z; Hussain K; Nair R; Steinman R Cardiol J; 2010; 17(5):509-11. PubMed ID: 20865683 [TBL] [Abstract][Full Text] [Related]
15. [An unusual cause of cardiac arrest]. Campana A; Manzo M; Brigante M; Marrazzo N; Melchiorre G Ital Heart J Suppl; 2003 Jun; 4(6):510-3. PubMed ID: 19400057 [TBL] [Abstract][Full Text] [Related]
16. Torsade de pointes induced by ioxaglate intracoronary injection in patients with pre-existent drug-induced QT prolongation: case reports and review of literature. Andréjak M; Leborgne L; Tribouilloy C; Andréjak MT; Caron J Fundam Clin Pharmacol; 2011 Jun; 25(3):296-9. PubMed ID: 20618873 [TBL] [Abstract][Full Text] [Related]